Risposta rapida — Cos'è il Tesamorelin?
Tesamorelin is a peptide supplied as a lyophilized powder for reconstitution. The information on this page describes published preclinical and early clinical literature; it is not medical advice or dosing guidance. Read our linked guide for the complete evidence summary.
Peptide Tesamorelin
Tesamorelin is a synthetic growth hormone–releasing hormone (GHRH) analog developed for studies involving endocrine modulation, growth hormone dynamics, and metabolic regulation. It binds to GHRH receptors in the anterior pituitary, stimulating controlled growth hormone secretion and downstream insulin-like growth factor-1 (IGF-1) signaling pathways. This mechanism makes it a valuable compound for studying lipid metabolism, body composition pathways, and hormonal regulation of adipose tissue in clinical models. Study applications include investigations into visceral fat signaling, metabolic efficiency, and age-related changes in GH activity. Its receptor-specific action provides a structured framework for examining hypothalamic-pituitary interactions and growth hormone–mediated metabolic processes in controlled clinical settings.
Panoramica del prodotto
Tesamorelin is a synthetic peptide classified as a stabilized growth hormone–releasing hormone (GHRH) analog intended strictly for clinical investigation. The Tesamorelin peptide features the molecular formula C221H366N72O67S and a molar mass of 5136 g/mol, reflecting its extended amino acid structure engineered for receptor specificity. This lyophilized Tesamorelin is supplied in sterile vials containing 2 mg, 5 mg, 10 mg, or 20 mg of total active ingredient in high purity lyophilized form. Image alt text: lyophilized Tesamorelin peptide vial 10mg high purity compound. Designed for stability under controlled storage conditions, Tesamorelin for studies maintains integrity for up to 36 months when stored as recommended.
Published Evidence
Tesamorelin is utilized in experimental clinical settings focused on endocrine signaling and metabolic pathway analysis. In vitro studies frequently evaluate receptor-binding affinity and downstream intracellular responses following GHRH receptor activation. Pre-clinical models employ the Tesamorelin peptide to investigate growth hormone pulsatility and IGF-1–associated signaling cascades. Users also examine lipid metabolism markers and adipose tissue signaling responses under controlled clinical conditions. Lyophilized Tesamorelin provides consistency for comparative clinical investigation across endocrine-focused study designs. Its defined molecular profile supports reproducible experimentation in regulated studies environments.
Ricostituzione e Manipolazione
Lyophilized Tesamorelin should be reconstituted using bacteriostatic water under strict aseptic technique within a controlled clinical environment. The diluent should be introduced slowly along the inner vial wall to preserve peptide stability and minimize agitation. Avoid shaking the vial; instead, gently swirl until the solution becomes clear and fully dissolved. Proper handling of the Tesamorelin peptide ensures structural integrity for clinical investigation. After reconstitution, the solution should be refrigerated at 2–8°C and protected from light exposure. All preparation procedures should follow standard clinical practice.
Meccanismo d'Azione
Tesamorelin functions as a selective agonist of GHRH receptors located in the anterior pituitary in pre-clinical models. Upon receptor binding, the Tesamorelin peptide stimulates cyclic AMP production and regulated growth hormone secretion within experimental systems. This activation supports downstream IGF-1 signaling pathways that are frequently examined in metabolic and endocrine studies. Tesamorelin for studies demonstrates receptor-targeted activity with minimized off-target interaction in controlled settings. Investigators utilize lyophilized Tesamorelin to analyze feedback mechanisms between hypothalamic and pituitary pathways. These mechanistic properties make it suitable for clinical investigation of growth hormone–mediated metabolic processes.
Linee guida per il dosaggio
Dosing ranges reported in published experimental literature vary depending on the specific in vitro studies or pre-clinical models employed. Concentration ranges are typically selected to evaluate receptor activation thresholds and hormonal response markers. In clinical investigation settings, dosing parameters are adjusted according to study endpoints and analytical objectives. Tesamorelin should be quantified using calibrated clinical equipment to ensure precision and reproducibility. Final protocol design remains the responsibility of qualified users operating under institutional compliance standards.
Potential Benefits
- Valutazione dei marcatori di attivazione del recettore dell'ormone della crescita
- Analisi delle risposte delle vie di segnalazione dell'IGF-1
- Osservazione degli indicatori del metabolismo lipidico nei modelli tissutali
- Test di stabilità in ambienti biologici simulati
- Analisi delle dinamiche dei circuiti di feedback endocrino
Osservazioni Sperimentali
Experimental observations of the Tesamorelin peptide in vitro studies demonstrate measurable receptor-mediated signaling activity. Clinical findings indicate consistent structural stability of lyophilized Tesamorelin when stored under recommended conditions. Pre-clinical models report reproducible endocrine response patterns aligned with GHRH receptor stimulation. Tesamorelin has shown predictable receptor interaction potential in controlled assays. Investigators note reliable activation of downstream signaling cascades relevant to metabolic pathway analysis. These findings reinforce its applicability in structured endocrine clinical investigation.
Considerations
Users utilizing the Tesamorelin peptide should ensure precise environmental controls to prevent degradation or contamination. Verification of peptide identity and batch consistency is recommended for advanced analytical studies. Lyophilized Tesamorelin must be handled exclusively by trained clinical personnel familiar with peptide protocols. Appropriate documentation and regulatory approvals should be secured prior to experimental use. Tesamorelin should remain confined to designated clinical facilities at all times. Careful procedural planning supports reproducibility and data integrity in experimental clinical settings. Standard clinical protective equipment should be worn during handling and preparation. Avoid inhalation, ingestion, or direct contact with skin and eyes. Dispose of all materials in accordance with institutional biosafety regulations. Users are responsible for compliance with applicable local, national, and international guidelines governing peptide studies. The information provided is for educational and scientific reference and should not be interpreted as medical advice or as a recommendation for any form of administration. Users should follow all applicable regulations and institutional guidelines when handling this material.
Informazioni sulla conservazione
For long-term preservation, Tesamorelin peptide should be stored at −20°C to maintain molecular stability. Short-term storage may be maintained at 2–8°C under refrigeration. Lyophilized Tesamorelin should be protected from light to prevent degradation. Avoid repeated freeze-thaw cycles, as they may compromise structural integrity and experimental consistency. When stored according to recommended guidelines, the shelf life is 36 months. Proper storage ensures Tesamorelin for studies maintains quality for extended clinical use.
Purezza e qualità
All Tesamorelin vials stocked by MedsBase are supplied at 99%+ HPLC purity in lyophilized form. A certificate of analysis (COA) is available on request — message our support team after placing your order and we will forward the batch-specific COA for the vials you received. It is sold. Some peptides in this class have been used in early-phase clinical trials but no major regulator has issued a marketing authorization for the indications discussed in the popular literature.
Come si ricostituisce il Tesamorelin?
I peptidi liofilizzati sono tipicamente ricostituiti con acqua batteriostatica o acqua sterile per iniezione (BWFI / SWFI) a una concentrazione appropriata per la dose pianificata. Aggiungere il diluente lentamente lungo la parete interna del flacone — non iniettare il flusso direttamente nella polvere o agitare vigorosamente, poiché entrambi denaturano il peptide. Agitare delicatamente fino a completa dissoluzione. I peptidi ricostituiti sono tipicamente conservati refrigerati a 2–8°C.
Come dovrebbe essere conservato il Tesamorelin?
I flaconi liofilizzati sono stabili per periodi prolungati quando conservati a −20°C o refrigerati a 2–8°C, lontano dalla luce diretta. Dopo la ricostituzione, la maggior parte dei peptidi è stabile per 14–30 giorni in frigorifero, a seconda del tampone e del peptide specifico. Leggere sempre il certificato di analisi incluso con il flacone per i dati di conservazione e stabilità raccomandati dal fornitore.
What does the published literature shows?
The published literature on Tesamorelin is summarized in our linked guide. We separate preclinical (rodent / cell-culture) data, where it is consistent and reproducible, from clinical-trial data, where evidence is typically thinner. We also flag where popular online claims outrun the published record.
È legale ordinare Tesamorelin a livello internazionale?
Peptides occupy an ambiguous regulatory space. Importation rules vary by country and have changed in several jurisdictions over the past few years. It is the buyer’s responsibility to confirm import legality in their destination country before ordering. MedsBase ships peptides worldwide via our dedicated peptide courier; orders that contravene the destination country’s import rules may be detained at customs.
Qual è l'emivita del Tesamorelin?
Tesamorelin has a plasma half-life of approximately 26–38 minutes in clinical studies of the approved Egrifta formulation — longer than native GHRH(1-44) due to the trans-3-hexenoic acid modification that protects against DPP-IV cleavage. Most protocols use once-daily subcutaneous administration.
In cosa differisce il Tesamorelin dal Sermorelin?
Il Tesamorelin è l'analogo completo del GHRH(1-44) con una modifica di acido grasso che ne prolunga l'emivita, mentre il Sermorelin è il frammento troncato GHRH(1-29) senza modifiche. Il Tesamorelin ha l'approvazione della FDA per la lipodistrofia associata all'HIV, fornendo un set di dati clinici più sviluppato. Entrambi stimolano il rilascio di GH ipofisario, ma il Tesamorelin ha una finestra d'azione leggermente più lunga.
Posso ordinare Tesamorelin insieme ad altri peptidi?
Yes. Peptide orders are bundled and ship together via our peptide-only courier service. Lyophilized vials are protective for the duration of standard international transit. See our peptide category page for the full stocked range and the “Best Peptides for Recovery” comparison guide for stacking considerations from the published literature.
Se il tuo protocollo abbina il rilascio di GH indotto dal GHRH del tesamorelin con peptidi riparatori localizzati per i tessuti, il nostro Peptide Healing Stack (BPC-157 5 mg + TB-500 5 mg + acqua batteriostatica) copre il livello di angiogenesi + riparazione citoscheletrica in un'unica spedizione alla tariffa di $0 per i peptidi.
Other Peptides for Recovery and Performance
- BPC-157 — Body Protection Compound — tendon, ligament, gut recovery
- TB-500 — Thymosin Beta-4 fragment — soft tissue and vascular recovery
- Ipamorelin — Agonista selettivo della grelina — pulso pulito di GH senza cortisolo/prolattina
- CJC-1295 con DAC — Analogico GHRH con emivita prolungata
- GHK-Cu — Copper peptide — skin and connective tissue regeneration
Approfondimenti
📖 Learn the science behind this peptide
Leggi la nostra guida completa basata sull'evidenza: Tesamorelin — benefits, dosage & the studies. Covers mechanism of action, published study data, typical dosing ranges, reconstitution protocols, stacking considerations, and safety/contraindication notes.
📦 Ogni ordine è coperto dalla nostra Politica di Garanzia di Rispedizione — se il tuo pacco non arriva entro 20 giorni lavorativi, lo rispediamo.
| Specifiche | Dettaglio |
|---|---|
| Numero CAS | 218949-48-5 |
| Formula Molecolare | C221H366N72O67S |
| Peso molecolare | 5135.86 Da |
| Sequenza | trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2 (GRF 1–44) |
| Forma | Polvere liofilizzata (o come fornito) |
| Purezza | ≥99% (verificato con HPLC, COA disponibile su richiesta) |
| Conservazione | Liofilizzato: 2–8 °C (frigorifero) per lo stock di lavoro; −20 °C per lo stoccaggio a lungo termine di flaconcini non aperti. Ricostituito: 2–8 °C, utilizzare entro ~30 giorni. Proteggere dalla luce. Non congelare e scongelare la soluzione ricostituita. |
| Solubilità | Acqua batteriostatica (consigliata) o acqua sterile per finestre d'uso più brevi |














Recensioni
Non ci sono ancora recensioni